TCA1 Compound Kills Persistent And Drug-Resistant Tuberculosis
A team of researchers has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.
Although isoniazid and rifampin, two front-…